|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
in00000115394 |
| 008 |
230616t20242024sz a b 001 0 eng d |
| 005 |
20241007175046.7 |
| 015 |
|
|
|a GBC3B6962
|2 bnb
|
| 016 |
7 |
|
|a 021096105
|2 Uk
|
| 020 |
|
|
|a 9783031300226
|q (hardback)
|
| 020 |
|
|
|a 303130022X
|q (hardback)
|
| 020 |
|
|
|z 9783031300233
|q (electronic book)
|
| 029 |
0 |
|
|a UKMGB
|b 021096105
|
| 035 |
|
|
|a (OCoLC)on1388637967
|
| 035 |
|
|
|a (OCoLC)1388637967
|
| 040 |
|
|
|a UKMGB
|b eng
|e rda
|c UKMGB
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCL
|d NTU
|d OCLCO
|d OCLCQ
|d COD
|
| 050 |
|
4 |
|a RS380
|b .P484 2024
|
| 060 |
|
4 |
|a QV 778
|
| 082 |
0 |
4 |
|a 615.19
|2 23
|
| 130 |
0 |
|
|a Pharmaceutical biotechnology (Crommelin)
|
| 245 |
1 |
0 |
|a Pharmaceutical biotechnology :
|b fundamentals and applications /
|c Daan J.A. Crommelin, Robert D. Sindelar, Bernd Meibohm, editors.
|
| 250 |
|
|
|a Sixth edition.
|
| 264 |
|
1 |
|a Cham, Switzerland :
|b Springer,
|c [2024]
|
| 264 |
|
4 |
|c ©2024
|
| 300 |
|
|
|a xxv, 682 pages :
|b color illustrations ;
|c 29 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 336 |
|
|
|a still image
|b sti
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Previous edition: 2019.
|
| 505 |
0 |
0 |
|g Part I.
|t Pharmaceutical biotechnology: the science, techniques, and important concepts --
|g 1.
|t Molecular biotechnology: from DNA sequence to therapeutic protein /
|r Olivier G. de Jong, Ronald S. Oosting --
|g 2.
|t Biophysical and biochemical characteristics of therapeutic proteins /
|r Wim Jiskoot, Daan J. A. Crommelin --
|g 3.
|t Stability and characterization of protein- and nucleotide-based therapeutics /
|r Atanas V. Koulov --
|g 4.
|t Production and purification of recombinant proteins /
|r Alfred Luitjens, Emile van Corven --
|g 5.
|t Formulation of biologics including biopharmaceutical considerations /
|r Daan J. A. Crommelin, Andrea Hawe, Wim Jiskoot --
|g 6.
|t Pharmacokinetics and pharmacodynamics of therapeutic proteins and nucleic acids /
|r Bernd Meibohm --
|g 7.
|t Immunogenicity of therapeutic proteins /
|r Theo Rispens, Wim Jiskoot, and Grzegorz Kijanka --
|g 8.
|t Monoclonal antibodies: from structure to therapeutic application /
|r Rong Deng, Junyi Li, C. Andrew Boswell, Amita Joshi, and Chunze Li --
|g 9.
|t Genomics, other “OMIC” technologies, precision medicine, and additional biotechnology-related techniques /
|r Robert D. Sindelar --
|g 10.
|t Economic considerations in medical biotechnology /
|r Amit S. Patel, Kartick P. Shirur --
|g 11.
|t Biosimilars: principles, regulatory framework, and societal aspects /
|r Arnold G. Vulto, Liese Barbier --
|g 12.
|t An evidence-based practice approach to evaluating biotechnologically derived medications /
|r James P. McCormack --
|g Part II.
|t Pharmaceutical biotechnology: oligonucleotides, genes and cells/cell subunits, vaccines—the science, techniques, and clinical use --
|g 13.
|t Oligonucleotides and mRNA therapeutics /
|r Erik Oude Blenke, Raymond M. Schiffelers, Enrico Mastrobattista --
|g 14.
|t Advanced therapy medicinal products: clinical, non-clinical, and quality considerations /
|r Enrico Mastrobattista, Erik Doevendans, Niek P. van Til, Vera Kemp, Jeroen de Vrij, and Karin Hoogendoorn --
|g 15. Vaccines /
|r Wim Jiskoot, Gideon F. A. Kersten, Enrico Mastrobattista, and Bram Slütter --
|g Part III.
|t Pharmaceutical biotechnology: the protein products of biotechnology and their clinical use—endogenous proteins and their variations --
|g 16.
|t Insulin /
|r Chad D. Paavola, Michael R. De Felippis, David P. Allen, Ashish Garg, James L. Sabatowski, Rattan Juneja et al. --
|g 17.
|t Hematopoietic growth factors /
|r Juan Jose Pérez-Ruixo, Wojciech Krzyzanski --
|g 18.
|t Recombinant coagulation factors and thrombolytic agents /
|r Koen Mertens, Alexander B. Meijer --
|g 19.
|t Follicle-stimulating hormone /
|r Tom Sam, Marc Bastiaansen, Keith Gordon --
|g 20.
|t Human growth hormone /
|r Le N. Dao, Barbara Lippe, Michael Laird, and Daan J. A. Crommelin --
|g 21.
|t Recombinant human deoxyribonuclease I /
|r Robert A. Lazarus, Jeffrey S. Wagener --
|g 22.
|t Interferons and interleukins /
|r Jean-Charles Ryff, Sidney Pestka, and Daan J. A. Crommelin --
|g Part IV.
|t Pharmaceutical biotechnology: the protein products of biotechnology and their clinical use—monoclonal antibodies and their variations --
|g 23.
|t Antibody-based biotherapeutics in cancer /
|r Jürgen Barth --
|g 24.
|t Antibody-based biotherapeutics in inflammatory diseases /
|r Yan Xu, Jia Chen, and Honghui Zhou --
|g 25.
|t Monoclonal antibodies in solid organ transplantation /
|r Nicole A. Pilch, Holly B. Meadows, and Rita R. Alloway --
|g 26.
|t Antibody-based biotherapeutics in migraine /
|r Willebrordus Petrus Johannes van Oosterhout.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|0 http://id.loc.gov/authorities/subjects/sh90004049
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|0 http://id.loc.gov/authorities/subjects/sh85100590
|
| 650 |
1 |
2 |
|a Technology, Pharmaceutical.
|
| 650 |
|
6 |
|a Biotechnologie pharmaceutique.
|
| 650 |
|
6 |
|a Techniques pharmaceutiques.
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology.
|2 fast
|
| 700 |
1 |
|
|a Crommelin, D. J. A.
|q (Daan J. A.),
|e editor.
|0 http://id.loc.gov/authorities/names/n89138187
|1 https://isni.org/isni/0000000115782349
|
| 700 |
1 |
|
|a Sindelar, Robert D.,
|e editor.
|0 http://id.loc.gov/authorities/names/no98063927
|1 https://isni.org/isni/0000000116745873
|
| 700 |
1 |
|
|a Meibohm, Bernd,
|e editor.
|0 http://id.loc.gov/authorities/names/nb2006023433
|1 https://isni.org/isni/0000000116758586
|
| 944 |
|
|
|a MARS - RDA ENRICHED
|
| 948 |
|
|
|h NO HOLDINGS IN COD - 3 OTHER HOLDINGS
|
| 948 |
|
|
|h NO HOLDINGS IN COD - 103 OTHER HOLDINGS
|
| 948 |
|
|
|h NO HOLDINGS IN COD - 4 OTHER HOLDINGS
|
| 994 |
|
|
|a Z0
|b COD
|
| 999 |
f |
f |
|i 50b95bf1-a9b6-4a8f-b10a-9c062e37abd3
|s f21d1776-f1e7-4bad-bb55-b9b3ab5ef510
|
| 952 |
f |
f |
|p Can circulate
|a University of Colorado Boulder
|b Boulder Campus
|c Norlin
|d Norlin Library - Science Stacks
|e RS380 .P484 2024
|h Library of Congress classification
|i book
|m U183073979058
|n 1
|
